H.R. 4623 · Where this bill is now
In committee
Introduced in the House, sent to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned, Jul 22, 2025
What this bill does
In plain words · AI-written from the official summaryRequires drug ads to show list prices
When you see a prescription drug commercial on TV, the drug maker would have to display the drug's list price right there in the ad—as text on the screen. This applies to drugs covered by Medicare or Medicaid, the government health programs. The Centers for Medicare & Medicaid Services would write the official rule to make this happen.
How it affects you
If you watch TV, you'd see drug prices displayed in advertisements, which could help you understand the cost before talking to your doctor. People on Medicare and Medicaid would see this price information for drugs their insurance covers. The main effect is more transparency about what medications actually cost.
Read the official summary (Introduced in House, Jul 22, 2025)
Plain Prescription Prices Act
This bill requires the Centers for Medicare & Medicaid Services to issue a rule requiring direct-to-consumer television advertisements for prescription drugs that are covered by Medicare or Medicaid to include a textual statement of the drug's list price.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionH. R. 4623
A BILL
Plain Prescription Prices Act
Sponsor: Rep. Nikema Williams (D-GA-5) · Introduced Jul 22, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Jul 22, 2025: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.”